Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Revenue (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Revenue for 6 consecutive years, with -$74051.0 as the latest value for Q4 2022.

  • Quarterly Revenue fell 185227.5% to -$74051.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was -$609129.0 through Dec 2022, down 91.17% year-over-year, with the annual reading at -$370276.0 for FY2025, 30.08% up from the prior year.
  • Revenue hit -$74051.0 in Q4 2022 for Kraig Biocraft Laboratories, up from -$74747.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $152230.0 in Q2 2018 to a low of -$298444.0 in Q2 2022.
  • Historically, Revenue has averaged -$52614.4 across 3 years, with a median of -$74399.0 in 2022.
  • Biggest five-year swings in Revenue: surged 417.09% in 2018 and later tumbled 185227.5% in 2022.
  • Year by year, Revenue stood at $140761.0 in 2018, then tumbled by 99.97% to $40.0 in 2021, then crashed by 185227.5% to -$74051.0 in 2022.
  • Business Quant data shows Revenue for KBLB at -$74051.0 in Q4 2022, -$74747.0 in Q3 2022, and -$298444.0 in Q2 2022.